Soji Soman

Soji Soman

Auto-generated profile, based on publicly available information

Soji Soman

Department of Pharmaceutics, SRM College of Pharmacy, Faculty of Medicine and Health Sciences SRM Institute of Science and Technology Chengalpattu Tamil Nadu India

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2024 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
ANAjinkya Nikam
Ajinkya Nikam
ARAmrita Roy
Amrita Roy
RRRuchira Raychaudhuri
Ruchira Raychaudhuri
PNPrerana D. Navti
Prerana D. Navti
SSSoji Soman
Soji Soman
SMSrinivas Mutalik
Srinivas Mutalik
Topical drug delivery holds immense significance in dermatological treatments due to its non-invasive nature and direct application to the target site. Organogels, a promising class of topical drug delivery systems, have acquired substantial attention for enhancing drug delivery efficiency. This review article aims to explore the advantages of organogels, including enhanced drug solubility, controlled release, improved skin penetration, non-greasy formulations, and ease of application. The mechanism of organogel permeation into the skin is discussed, along with formulation strategies, which encompass the selection of gelling agents, cogelling agents, and additives while considering the influence of temperature and pH on gel formation. Various types of organogelators and organogels and their properties, such as viscoelasticity, non-birefringence, thermal stability, and optical clarity, are presented. Moreover, the biomedical applications of organogels in targeting skin cancer, anti-inflammatory drug delivery, and antifungal drug delivery are discussed. Characterization parameters, biocompatibility, safety considerations, and future directions in optimizing skin permeation, ensuring long-term stability, addressing regulatory challenges, and exploring potential combination therapies are thoroughly examined. Overall, this review highlights the immense potential of organogels in redefining topical drug delivery and their significant impact on the field of dermatological treatments, thus paving the way for exciting prospects in the domain.

14 April 2026 in Packaging Technology and Science
Verified
Journal Article
Closed access
PDF file
CTChandrika S. Tantry
Chandrika S. Tantry
ARAnjali Raghuram
Anjali Raghuram
MBManasa S. B.
Manasa S. B.
NDNishma D
Nishma D
RSRashi R. Shetty
Rashi R. Shetty
VMVidya Shimoga Muddappa
Vidya Shimoga Muddappa

1 October 2026 in Advanced Healthcare Materials
Verified
Journal Article
Open access
PDF file
MIMohamed Nawfal Ibraheam
Mohamed Nawfal Ibraheam
VSVijayabharathi Saravanan
Vijayabharathi Saravanan
LNLavanya N
Lavanya N
SSSoji Soman
Soji Soman
FSFarhath Sherin
Farhath Sherin
Chronic wounds remain a major healthcare challenge because persistent inflammation, biofilm formation, oxidative stress, protease imbalance, hypoxia, and impaired angiogenesis prevent progression through normal healing. Conventional wound dressings provide passive protection but cannot continuously monitor the dynamic wound microenvironment or deliver adaptive therapy. Unlike previous reviews that independently summarize wound biosensors, responsive biomaterials, or drug‐delivery systems, this review critically integrates the complete closed‐loop paradigm of intelligent wound management, from single‐ and multi‐stimuli‐responsive sensing to AI‐assisted autonomous therapeutic intervention. Chemical and physical sensing modalities are comparatively evaluated based on analytical performance, selectivity, clinical readiness, and translational limitations, while multi‐responsive logic‐gated platforms are assessed against conventional single‐stimulus systems. The review further synthesizes available human clinical evidence, compares fabrication strategies and manufacturing scalability, and discusses regulatory pathways governing combination products, Software as a Medical Device, and AI‐enabled wound care. Particular emphasis is placed on AI model development, data quality, validation, bias mitigation, and cybersecurity requirements for safe clinical deployment. Finally, major barriers including material scalability, long‐term biocompatibility, sensor robustness, standardized clinical validation, and regulatory governance are critically analyzed to establish a translational framework for developing clinically reliable, intelligent smart bandages capable of precision management of chronic wounds.

28 August 2026 in Polymers for Advanced Technologies
Verified
Journal Article
Closed access
PDF file
AGAshutosh Gupta
Ashutosh Gupta
ANAniket Navale
Aniket Navale
DGDebadrita Ghosh
Debadrita Ghosh
PJParekh Nirmit Jigneshkumar
Parekh Nirmit Jigneshkumar
KKKuljeet Kaur
Kuljeet Kaur
SESally A. El‑Zahaby
Sally A. El‑Zahaby

31 July 2026 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
ARAditya Dev Rajora
Aditya Dev Rajora
PHPraveen Halagali
Praveen Halagali
ARAmrita Roy
Amrita Roy
FSFarhath Sherin
Farhath Sherin
MSMoumita Saha
Moumita Saha
SSSoji Soman
Soji Soman
Dermatoses comprise a diverse group of skin disorders that compromise skin integrity, adversely affect patient health, and significantly reduce quality of life. These conditions are often associated with inflammation, infection, and disease progression, necessitating personalized therapeutic strategies and long-term management. Recent advances in molecular biology have facilitated the identification of biomarkers associated with disease onset, progression, and treatment response. These biomarkers provide valuable insights into disease pathophysiology and support early diagnosis, prognosis, and therapeutic monitoring. This review presents a comprehensive overview of gene expression profiles and biomarkers associated with various dermatological disorders. Understanding biomarker signatures enables the development of targeted and personalized therapeutic approaches tailored to individual patients, thereby improving treatment efficacy and clinical outcomes. In addition, this review highlights the role of nanocarrier-based systems in dermal drug delivery. Compared with conventional formulations, nanoparticle-based nanocarriers improve drug stability, enhance bioavailability, enable controlled drug release, minimize systemic toxicity, and reduce off-target drug delivery, making them promising platforms for the effective management of dermatological disorders.